Asia Deal Watch: Zogenix Partners Japanese Rights To Pediatric Epilepsy Therapy To Nippon Shinyaku

 
• By Ian Haydock, Anju Ghangurde, Jung Won Shin, and Joseph Haas

Nippon Shinyaku obtains rights to sell Dravet and Lennox-Gastaut syndrome drug Fintepla in its home market. Sun Pharma increases its ownership stake in Russia’s PJSC Biosintez.

Japanese flag

More from Focus On Asia

More from Scrip